Statistics
Publications
3
Citations
292
H-Index
3
Active since
2014
Affiliations
Hong-Tu Zheng is an author at Fudan University Shanghai Cancer Center specializing in molecular oncology, colorectal cancer, and colorectal cancer biomarkers.
Publications per year
2014–2014
3
3
High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
Hong-Tu Zheng, De-Bing Shi, Yuwei Wang et al. · PubMed · 2014 · 261 citations
RNA-seq reveals determinants for irinotecan sensitivity/resistance in colorectal cancer cell lines.
Xin-Xiang Li, Hong-Tu Zheng, Jun-Jie Peng et al. · PubMed · 2014 · 18 citations
Medicine, Oncology, Pharmacology +17
RNA-seq identifies determinants of oxaliplatin sensitivity in colorectal cancer cell lines.
Xin-Xiang Li, Jun-Jie Peng, Lei Liang et al. · PubMed · 2014 · 13 citations
Medicine, Oncology, Pharmacology +17
1–3 of 3